DNA repair pathway score for predicting chemotherapy response in ovarian cancer patients
A DNA repair pathway-focused score has the potential to help determine if first-line platinum based chemotherapy can benefit advanced-stage ovarian cancer patients, according to a study. Most ovarian cancer patients are diagnosed with advanced disease (stages III and IV). They undergo surgery to remove as much tumour as possible, and then undergo platinum-based chemotherapy. But […]
